Neochem Bio Solutions Key Ratios
NSE: NEOCHEM
₹101.90
₹3.90
(3.98%)
As on 31-Aug-2026 11:23IST
Market cap
₹168 Cr
Revenue (TTM)
₹84 Cr
P/E Ratio
13.9
P/B Ratio
2.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 37.66 | -- | -- |
| EBIT | -- | -- | 147.05 | -- | -- |
| Net Profit | -- | -- | 330.28 | -- | -- |
| EPS | -- | -- | 330.30 | -- | -- |
| Book Value | -- | -- | 64.58 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 14.00 | 7.80 | 6.24 |
| Net Margin
| -- | -- | 9.00 | 2.90 | 2.20 |
| Return on equity
| -- | -- | 48.82 | 17.96 | 13.33 |
| Return on Capital
| -- | -- | 27.34 | 14.15 | 10.54 |
| Return on Assets
| -- | -- | 10.84 | 3.14 | 2.12 |
| Debt to Equity (x)
| -- | -- | 1.80 | 2.78 | 3.26 |
Profitability
ROCE
27.34
Higher than Peers by 17.46
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
27.34
|
14.15
|
10.54
|
--
|
--
|
|
Peer Median
|
9.88
|
12.69
|
20.70
|
5.72
|
--
|
ROE
48.82
Higher than Peers by 41.39
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
48.82
|
17.96
|
13.33
|
--
|
--
|
|
Peer Median
|
7.42
|
10.08
|
19.72
|
1.42
|
--
|
ROA
10.84
Higher than Peers by 6.58
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
10.84
|
3.14
|
2.12
|
--
|
--
|
|
Peer Median
|
4.26
|
3.39
|
7.22
|
0.76
|
--
|
EBIT Margin
14.00
Higher than Peers by 9.81
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
14.00
|
7.80
|
6.24
|
--
|
--
|
|
Peer Median
|
4.19
|
7.38
|
9.34
|
12.48
|
--
|
Net Margin
9.00
Higher than Peers by 5.49
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
9.00
|
2.90
|
2.20
|
--
|
--
|
|
Peer Median
|
3.51
|
3.20
|
7.33
|
0.46
|
--
|
Cash Profit Margin
10.79
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
10.79
|
4.94
|
4.75
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
37.66
Higher than Peers by 30.02
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
37.66
|
26.89
|
--
|
--
|
--
|
|
Peer Median
|
7.64
|
29.09
|
31.46
|
45.78
|
--
|
EBIT Growth
147.05
Higher than Peers by 125.35
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
147.05
|
58.54
|
--
|
--
|
--
|
|
Peer Median
|
21.70
|
81.59
|
19.00
|
462.95
|
--
|
Net Profit Growth
330.28
Higher than Peers by 341.38
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
330.28
|
67.89
|
--
|
--
|
--
|
|
Peer Median
|
-11.10
|
106.26
|
41.20
|
290.04
|
--
|
EPS Growth
330.28
Higher than Peers by 362.55
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
330.28
|
36.48
|
--
|
--
|
--
|
|
Peer Median
|
-32.27
|
--
|
102.60
|
290.04
|
--
|
Book Value Growth
64.58
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
64.58
|
49.07
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.80
Higher than Peers by 1.10
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.80
|
2.78
|
3.26
|
--
|
--
|
|
Peer Median
|
0.70
|
0.81
|
0.82
|
1.08
|
--
|
Short term debt to equity ratio
1.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.01
|
1.16
|
1.41
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.21
Higher than Peers by 0.19
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.21
|
1.17
|
1.09
|
--
|
--
|
|
Peer Median
|
1.02
|
1.32
|
1.33
|
1.08
|
--
|
Quick Ratio
0.67
Lower than Peers by 0.58
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
0.67
|
0.62
|
0.58
|
--
|
--
|
|
Peer Median
|
1.24
|
0.57
|
0.59
|
1.17
|
--
|
Interest Coverage
3.93
Higher than Peers by 1.88
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
3.93
|
1.90
|
1.72
|
--
|
--
|
|
Peer Median
|
2.05
|
1.93
|
3.69
|
0.95
|
--
|
Operating Efficiency
Debtors to sales
30.03
Higher than Peers by 19.31
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
30.03
|
28.20
|
29.91
|
--
|
--
|
|
Peer Median
|
10.72
|
14.68
|
6.56
|
19.69
|
--
|
Asset Turnover
1.18
Lower than Peers by 0.18
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.18
|
1.07
|
0.95
|
--
|
--
|
|
Peer Median
|
1.35
|
1.28
|
1.50
|
1.30
|
--
|
Receivable days
92.18
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
92.18
|
94.48
|
109.19
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
90.99
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
90.99
|
98.91
|
113.09
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
100.44
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
100.44
|
130.08
|
156.95
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
82.73
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
82.73
|
63.31
|
65.33
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
26.26
|
17.22
|
12.36
|
7.96
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.85
|
1.07
|
0.87
|
1.40
|
--
|
EV/EBITDA
2.80
Lower than Peers by 10.55
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
2.80
|
5.79
|
6.55
|
--
|
--
|
|
Peer Median
|
13.35
|
6.29
|
3.30
|
13.29
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
89
|
79
|
141
|
112
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
